Home
Abcuro

Abcuro Market Share Analysis for June 2026

Learn about open positions at Abcuro. At Abcuro, we’re dedicated to developing breakthrough therapeutics for high unmet needs in autoimmune disease and cancer. To achieve this important goal, we have assembled an experienced and dedicated team that shares a passion for bringing meaningful therapeutic advances to patients.

Industry: N/A

Domainabcuro.com

Year Founded2015

Employees51 - 200

Annual Revenue$2M - $5M

Abcuro

Abcuro (including company regionals)

abcuro.com

See more website traffic and engagement information

Abcuro Revenue up to June 2026 is 2M - 5M

revenue generated by Abcuro top domains

Abcuro top domains revenue over 3 years

Revenue for Abcuro top domains

abcuro.com2M - 5M

See more with Sales Intelligence

Total visits to Abcuro's top domains

Understand Abcuro market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

abcuro.com2.6K

See more with Sales Intelligence

Avg. visit duration in Abcuro's top domains

Analyze Abcuro engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

abcuro.com00:00:38

See more with Sales Intelligence

Avg. pageviews on Abcuro's top domains

See how Abcuro keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

abcuro.com1.95

See more with Sales Intelligence

Abcuro top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Abcuro

These are the website technologies, by industry, used by Abcuro top domains

Widget (4)

Twemoji

Content Management System (3)

WordPress

Mobile (2)

Meta Viewport

Advertising (1)

PubMatic

More Technologies

5

See all

News & Signals from Abcuro

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAbcuro, Inc hired George Eldridge as Chief Financial Officer on Aug 18th '25.Newton, Massachusetts, August 18, 2025 - Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced the appointment of George Eldridge as Chief Financial Officer (CFO).

NewsAbcuro, Inc hired Courtney Cupples as Chief Commercial Officer on Jun 9th '25.Newton, Massachusetts, June 9, 2025 - Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced the appointment of Courtney Cupples as Chief Commercial Officer (CCO).

NewsAbcuro, Inc attends event American Academy of Neurology 2025 Annual Meeting.Abcuro to present two posters at the American Academy of Neurology 2025 Annual Meeting.